Alliancebernstein L.P. Phathom Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 50,110 shares of PHAT stock, worth $439,965. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,110

Previous 50,110 -0.0%

Holding current value

$439,965

Previous $516,000 75.39%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$8.97 - $12.05 $159,845 - $214,731	17,820 Added 55.19%	50,110 $516,000
Q1 2024 May 14, 2024	SELL	$6.21 - $11.05 $33,596 - $59,780	-5,410 Reduced 14.35%	32,290 $342,000
Q2 2023 Aug 15, 2023	BUY	$7.28 - $14.32 $75,712 - $148,928	10,400 Added 38.1%	37,700 $539,000
Q1 2023 May 15, 2023	BUY	$6.19 - $12.36 $29,712 - $59,328	4,800 Added 21.33%	27,300 $194,000
Q4 2022 Feb 14, 2023	BUY	$9.18 - $11.53 $61,506 - $77,251	6,700 Added 42.41%	22,500 $252,000
Q3 2022 Nov 15, 2022	BUY	$6.46 - $12.11 $7,752 - $14,532	1,200 Added 8.22%	15,800 $175,000
Q2 2022 Aug 15, 2022	BUY	$6.2 - $15.5 $17,980 - $44,950	2,900 Added 24.79%	14,600 $123,000
Q1 2022 May 13, 2022	SELL	$11.55 - $20.06 $13,860 - $24,072	-1,200 Reduced 9.3%	11,700 $159,000
Q4 2021 Feb 14, 2022	BUY	$17.83 - $33.15 $33,877 - $62,985	1,900 Added 17.27%	12,900 $254,000
Q3 2021 Nov 10, 2021	SELL	$30.69 - $36.83 $39,897 - $47,879	-1,300 Reduced 10.57%	11,000 $353,000
Q2 2021 Jul 30, 2021	BUY	$32.66 - $39.87 $58,787 - $71,766	1,800 Added 17.14%	12,300 $416,000
Q1 2021 May 06, 2021	SELL	$33.86 - $48.68 $30,474 - $43,812	-900 Reduced 7.89%	10,500 $394,000
Q4 2020 Feb 08, 2021	SELL	$33.22 - $50.26 $23,254 - $35,182	-700 Reduced 5.79%	11,400 $379,000
Q3 2020 Nov 12, 2020	SELL	$29.24 - $40.19 $55,556 - $76,361	-1,900 Reduced 13.57%	12,100 $444,000
Q2 2020 Aug 13, 2020	BUY	$25.06 - $54.6 $350,840 - $764,400	14,000 New	14,000 $461,000

Others Institutions Holding PHAT

# of Institutions

144

Shares Held

73.6M

Call Options Held

42.3K

Put Options Held

45.7K

View Full List

About Phathom Pharmaceuticals, Inc.

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $344M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

More about PHAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Phathom Pharmaceuticals, Inc. Transaction History